Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919103302AGB9103302D0 (en) | 1991-02-16 | 1991-02-16 | Pharmaceutical formulations |
AU12272/92AAU1227292A (en) | 1991-02-16 | 1992-02-13 | Pharmaceutical antitussive compositions |
PCT/GB1992/000257WO1992014466A1 (en) | 1991-02-16 | 1992-02-13 | Pharmaceutical antitussive compositions |
ZA921093AZA921093B (en) | 1991-02-16 | 1992-02-14 | Pharmaceutical formulations |
IE048492AIE920484A1 (en) | 1991-02-16 | 1992-02-14 | Pharmaceutical Formulations |
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919103302AGB9103302D0 (en) | 1991-02-16 | 1991-02-16 | Pharmaceutical formulations |
Publication Number | Publication Date |
---|---|
GB9103302D0true GB9103302D0 (en) | 1991-04-03 |
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB919103302APendingGB9103302D0 (en) | 1991-02-16 | 1991-02-16 | Pharmaceutical formulations |
Country | Link |
---|---|
AU (1) | AU1227292A (en) |
GB (1) | GB9103302D0 (en) |
IE (1) | IE920484A1 (en) |
WO (1) | WO1992014466A1 (en) |
ZA (1) | ZA921093B (en) |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU676025B2 (en)* | 1993-03-29 | 1997-02-27 | Henry, Richard A. Dr | Lidocaine aerosol anaesthetic |
US5593661A (en)* | 1993-03-29 | 1997-01-14 | Henry; Richard A. | Lidocaine aerosol anaesthetic |
US5589156A (en)* | 1994-05-02 | 1996-12-31 | Henry; Richard A. | Prilocaine and hydrofluourocarbon aerosol preparations |
SE9601528D0 (en)* | 1996-04-23 | 1996-04-23 | Pharmacia Ab | Transdermally administered dextromethorphan as an antitissue agent |
JP2002517438A (en)* | 1998-06-09 | 2002-06-18 | ノートラン・ファーマシューティカルズ・インコーポレーテッド | Compositions and methods for treating cough |
CA2354576C (en)* | 1998-12-11 | 2008-10-14 | Pharmachemie B.V. | Pharmaceutical preparation for inhalation of an opioid |
IL153574A0 (en) | 2000-06-23 | 2003-07-06 | Mayo Foundation | Methods of treating neutrophil-related diseases with topical anesthetics |
EP1506174B1 (en)* | 2002-05-17 | 2015-09-30 | Taiwanj Pharmaceuticals Co., Ltd. | Use of naltrexone for treating kidney and liver damage |
EP2218448B1 (en) | 2002-12-13 | 2015-09-23 | Durect Corporation | Oral drug delivery system comprising high viscosity liquid carrier materials |
EP2559428A1 (en)* | 2007-12-06 | 2013-02-20 | Pain Therapeutics, Inc. | Micronized opioid compositions and dosage forms and methods of making same |
JP2011506318A (en) | 2007-12-06 | 2011-03-03 | デュレクト コーポレーション | Oral pharmaceutical formulation |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
US9555113B2 (en) | 2013-03-15 | 2017-01-31 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
SG11201811760VA (en) | 2016-07-06 | 2019-01-30 | Durect Corp | Oral dosage form with drug composition, barrier layer and drug layer |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1136547A (en)* | 1979-03-08 | 1982-11-30 | Song-Ling Lin | Aerosol anesthetic compositions |
US4241048A (en)* | 1979-05-01 | 1980-12-23 | Bristol-Myers Company | Suspension composition of benzocaine |
US4454140A (en)* | 1982-09-07 | 1984-06-12 | Hoffmann-La Roche Inc. | Nasal administration of dextromethorphan |
IT1187743B (en)* | 1985-09-26 | 1987-12-23 | Prodotti Formenti Srl | DESTRORPHANE BASED PHARMACEUTICAL COMPOSITIONS FOR INSTRANASAL APPLICATION |
FR2601246B1 (en)* | 1986-07-11 | 1990-01-05 | Bouchara Sa | NOVEL DEXTROMETHORPHANE-BASED ANTI-TUSSIVE COMPOSITIONS AND THEIR PROCESS FOR OBTAINING SAME. |
Publication number | Publication date |
---|---|
WO1992014466A1 (en) | 1992-09-03 |
AU1227292A (en) | 1992-09-15 |
ZA921093B (en) | 1993-01-27 |
IE920484A1 (en) | 1992-08-26 |
Publication | Publication Date | Title |
---|---|---|
GB9109862D0 (en) | Pharmaceutical formulations | |
ZA921877B (en) | Pharmaceutical aerosol formulations | |
IL102777A0 (en) | Pharmaceutical combination formulation | |
ZA921093B (en) | Pharmaceutical formulations | |
GB9114950D0 (en) | Pharmaceutical formulation | |
AP9000236A0 (en) | Pharmaceutical formulations | |
GB9201639D0 (en) | Pharmaceutical formulations | |
GB9323399D0 (en) | Pharmaceutical formulations | |
GB9311030D0 (en) | Pharmaceutical formulations | |
GB9216061D0 (en) | Pharmaceutical combination formulation | |
GB9103444D0 (en) | Pharmaceutical formulations | |
GB9102019D0 (en) | Pharmaceutical formulations | |
GB9111858D0 (en) | Pharmaceutical formulations | |
GB9124803D0 (en) | Pharmaceutical formulations | |
GB9125005D0 (en) | Pharmaceutical formulations | |
GB9114621D0 (en) | Pharmaceutical formulations | |
GB9014391D0 (en) | Pharmaceutical formulations | |
GB9204774D0 (en) | Pharmaceutical formulations | |
GB9221244D0 (en) | Pharmaceutical formulations | |
GB9307003D0 (en) | Pharmaceutical formulations | |
GB9203212D0 (en) | Pharmaceutical formulations | |
GB9217602D0 (en) | Pharmaceutical formulations | |
GB9207338D0 (en) | Pharmaceutical formulations | |
GB9121798D0 (en) | Pharmaceutical formulation | |
GB9116467D0 (en) | Pharmaceutical formulation |